Advertisement

Topics

Private equity firm snaps up Parexel

03:31 EDT 21 Jun 2017 | BioPharmaDive

Pamplona Capital's $5 billion deal for Parexel is the latest in a string of takeovers and mergers that have shaken up the contract research space.

Original Article: Private equity firm snaps up Parexel

NEXT ARTICLE

More From BioPortfolio on "Private equity firm snaps up Parexel"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...